Abstract:Abstract Background Breast cancer is the most prevalent and among the most deadly cancers in females. Patients with breast cancer have highly variable survival lengths, indicating a need to identify prognostic biomarkers for personalized diagnosis and treatment. With the development of new technologies such as next-generation sequencing, multi-omics information are becoming available for a more thorough evaluation of a patient’s condition. In this study, we aim to improve breast cancer overall survival prediction by integrating multi-omics data (e.g., gene expression, DNA methylation, miRNA expression, and copy number variations (CNVs)). Methods Motivated by multi-view learning, we propose a novel strategy to integrate multi-omics data for breast cancer survival prediction by applying complementary and consensus principles. The complementary principle assumes each -omics data contains modality-unique information. To preserve such information, we develop a concatenation autoencoder (ConcatAE) that concatenates the hidden features learned from each modality for integration. The consensus principle assumes that the disagreements among modalities upper bound the model errors. To get rid of the noises or discrepancies among modalities, we develop a cross-modality autoencoder (CrossAE) to maximize the agreement among modalities to achieve a modality-invariant representation. We first validate the effectiveness of our proposed models on the MNIST simulated data. We then apply these models to the TCCA breast cancer multi-omics data for overall survival prediction. Results For breast cancer overall survival prediction, the integration of DNA methylation and miRNA expression achieves the best overall performance of 0.641 ± 0.031 with ConcatAE, and 0.63 ± 0.081 with CrossAE. Both strategies outperform baseline single-modality models using only DNA methylation (0.583 ± 0.058) or miRNA expression (0.616 ± 0.057). Conclusions In conclusion, we achieve improved overall survival prediction performance by utilizing either the complementary or consensus information among multi-omics data. The proposed ConcatAE and CrossAE models can inspire future deep representation-based multi-omics integration techniques. We believe these novel multi-omics integration models can benefit the personalized diagnosis and treatment of breast cancer patients.

Multimodal CustOmics: A Unified and Interpretable Multi-Task Deep Learning Framework for Multimodal Integrative Data Analysis in Oncology

Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis

Multimodal Survival Ensemble Network: Integrating Genomic and Histopathological Insights for Enhanced Cancer Prognosis.

Integrative data analysis of multi-platform cancer data with a multimodal deep learning approach

Deep learning with multimodal representation for pancancer prognosis prediction

Integrating Multi-Modal Cancer Data Using Deep Latent Variable Path Modelling

MMCL-CDR: enhancing cancer drug response prediction with multi-omics and morphology images contrastive representation learning

Cohort-Individual Cooperative Learning for Multimodal Cancer Survival Analysis

A Multi-modal Fusion Framework Based on Multi-task Correlation Learning for Cancer Prognosis Prediction

Pancancer survival prediction using a deep learning architecture with multimodal representation and integration

Integrating Heterogeneous Datasets by Using Multimodal Deep Learning

Multi-omics and deep learning provide a multifaceted view of cancer

Hierarchical multimodal fusion framework based on noisy label learning and attention mechanism for cancer classification with pathology and genomic features

Multimodal Data Integration for Precision Oncology: Challenges and Future Directions

TMODINET: A trustworthy multi-omics dynamic learning integration network for cancer diagnostic

Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer

Integration of Multimodal Data from Disparate Sources for Identifying Disease Subtypes

Multimodal data integration for oncology in the era of deep neural networks: a review

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

Multi-task deep latent spaces for cancer survival and drug sensitivity prediction

MBFusion: Multi-modal balanced fusion and multi-task learning for cancer diagnosis and prognosis